Matthew Foy

Matthew Foy is a seasoned professional in the biotech and investment sectors with extensive experience spanning over a decade. Currently serving as a Partner at SR One Capital Management since June 2011, Foy has played a crucial role in building elite biotechnology companies. As an Investor Director at Econic Biosciences and Xap Therapeutics, Foy focuses on innovative solutions in cancer treatments and synthetic biology, respectively. Foy holds board positions at Fore Biotherapeutics and Pulmocide Limited, contributing to the development of advanced cancer therapies and respiratory treatments. Additionally, Foy supports young artists through Art Patron and engages in strategic fundraising for The Grange Festival. Academic credentials include BSc and MSc in Biological Sciences from the University of Oxford and further studies in entrepreneurship and strategy from UCL and London Business School.